Ozempic-Maker Novo and Wind Giant Orsted Made Denmark Rich. Are the Boom Times Now Over?

Ozempic-maker Novo and wind giant Orsted made Denmark rich. Are the boom times now over?

There are fears Denmark is facing a so-called “Nokia risk”. Read more at straitstimes.com.

Novo and Orsted Made Denmark Rich. Are The Boom Times Now Over?

(Bloomberg) — At their heights, Denmark’s corporate champions seemed untouchable. Novo Nordisk A/S, long known mostly as an insulin maker, was Europe’s most valuable company last year, after riding a surge of demand for Ozempic and Wegovy. That followed the success of Orsted A/S, the world’s largest offshore wind developer, which in 2021 was celebrating record valuations and racing to expand internationally as governments poured money into green…